Back to results
US 2010/0168081 A1Published application
Galantamine as a neuroprotective drug for retinal ganglion cells
OwnerAdriana Di Poloinventor
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of galantamine for neuroprotection of retinal ganglion cells.
Claims15
A method of neuroprotecting retinal ganglion cells comprising administering to a subject in need thereof a therapeutically or prophylactically effective amount of galantamine, or a derivative, stereoisomer, analog or pharmaceutically acceptable salt thereof.
15-20. (canceled)
Dependencies are inferred from the claim text.